Treatment of acquired factor VIII inhibitor with recombinant activated factor VIIa: data from the Italian registry of acquired hemophilia.

Abstract:

:We report on the data collected in the Italian Registry of acquired haemophilia (AH) in 2001. Recombinant activated factor VII (rFVIIa) was selected as first-line therapy in 19 bleeding episodes because of their severity and as salvage in one case. Bleeding was controlled in 90% of the episodes, indicating the efficacy of rFVIIa in HA.

journal_name

Haematologica

journal_title

Haematologica

authors

Baudo F,de Cataldo F,Gaidano G,Italian registry of acquired hemophilia.

keywords:

subject

Has Abstract

pub_date

2004-06-01 00:00:00

pages

759-61

issue

6

eissn

0390-6078

issn

1592-8721

journal_volume

89

pub_type

信件
  • Influence of two different Escherichia coli asparaginase preparations on fibrinolytic proteins in childhood ALL.

    abstract:BACKGROUND:Alterations in hemostasis have frequently been observed in patients with leukemia, and thrombotic events are well documented in patients receiving L-asparaginase (ASP) as a single agent or in combination with vincristine, prednisone (sometimes complemented by an anthracycline). The present study was designed...

    journal_title:Haematologica

    pub_type: 临床试验,杂志文章

    doi:

    authors: Nowak-Göttl U,Werber G,Ziemann D,Ahlke E,Boos J

    更新日期:1996-03-01 00:00:00

  • Cost-effectiveness and clinical outcomes of double versus single cord blood transplantation in adults with acute leukemia in France.

    abstract::Double cord blood transplantation extends the use of cord blood to adults for whom a single unit is not available, but the procedure is limited by its cost. To evaluate outcomes and cost-effectiveness of double compared to single cord blood transplantation, we analyzed 134 transplants in adults with acute leukemia in ...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2013.092254

    authors: Labopin M,Ruggeri A,Gorin NC,Gluckman E,Blaise D,Mannone L,Milpied N,Yakoub-Agha I,Deconinck E,Michallet M,Fegueux N,Socié G,Nguyen S,Cahn JY,de Revel T,Garnier F,Faucher C,Taright N,Kenzey C,Volt F,Bertrand D,M

    更新日期:2014-03-01 00:00:00

  • Progression to acquired immunodeficiency syndrome in 94 human immunodeficiency virus-positive hemophiliacs with long-term follow-up.

    abstract:BACKGROUND AND OBJECTIVES:Human immunodeficiency virus (HIV) infection was transmitted to many hemophilics treated with non-inactivated factor concentrates before 1986. The aim of this study was to know the long-term incidence of AIDS and risk factors for its development in HIV-infected hemophiliacs. DESIGN AND METHOD...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Lorenzo JI,Moscardó F,López-Aldeguer J,Aznar JA

    更新日期:2001-03-01 00:00:00

  • Resolving T-cell receptor clonality in two and genotype in four multiplex polymerase chain reactions.

    abstract:BACKGROUND AND OBJECTIVES:The diagnosis of T-cell neoplasia requires the use of immunohistochemistry on tumor sections or molecular genetic analysis of T-cell receptor (TCR) clonality. Multiplex polymerase chain reactions (PCR) offer a sensitive and expeditious approach to determining clonality early in the diagnostic ...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Dictor M,Warenholt J,Isinger A

    更新日期:2005-11-01 00:00:00

  • Comparison of genetic and clinical aspects in patients with acute myeloid leukemia and myelodysplastic syndromes all with more than 50% of bone marrow erythropoietic cells.

    abstract:BACKGROUND:The World Health Organization separates acute erythroid leukemia (erythropoiesis in ≥50% of nucleated bone marrow cells; ≥20% myeloblasts of non-erythroid cells) from other entities with increased erythropoiesis - acute myeloid leukemia with myelodysplasia-related changes (≥20% myeloblasts of all nucleated c...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2011.043687

    authors: Bacher U,Haferlach C,Alpermann T,Kern W,Schnittger S,Haferlach T

    更新日期:2011-09-01 00:00:00

  • SIGLEC-G deficiency increases susceptibility to develop B-cell lymphoproliferative disorders.

    abstract::The sialic-acid-binding immunoglobulin-like lectin SIGLEC-G is a negative regulator of B-cell receptor-mediated calcium signaling. Its deficiency leads to reduced turnover and increased proliferation and survival of murine B-1a cells. Siglecg(-/-) mice show a premature expansion of polyclonal CD5(+) B cells in the spl...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2013.100230

    authors: Simonetti G,Bertilaccio MT,Rodriguez TV,Apollonio B,Dagklis A,Rocchi M,Innocenzi A,Casola S,Winkler TH,Nitschke L,Ponzoni M,Caligaris-Cappio F,Ghia P

    更新日期:2014-08-01 00:00:00

  • Osteonecrosis after allogeneic stem cell transplantation in childhood. A case-control study in Italy.

    abstract::A case-control study was conducted among Italian children treated with a stem cell transplant (SCT). Cases (n = 43) were allogeneic recipients with osteonecrosis, and the controls (n = 129) were matched to the corresponding cases on the basis of survival, SCT center and date of transplant. Univariate analysis showed t...

    journal_title:Haematologica

    pub_type: 杂志文章,多中心研究

    doi:

    authors: Faraci M,Calevo MG,Lanino E,Caruso S,Messina C,Favr C,Iori A,Santaron S,Bonanomi S,Rondelli R,Dini G,Haupt R,AIEOP-SCT Group.

    更新日期:2006-08-01 00:00:00

  • Optimizing peripheral blood progenitor cell autologous transplantation in multiple myeloma.

    abstract::As in other malignancies, peripheral blood progenitor cells (PBPC) have almost completely replaced bone marrow as the source of stem cells for autologous transplantation in multiple myeloma. PBPC collection could be optimized either by reducing contamination by the malignant clone or by increasing hematopoietic qualit...

    journal_title:Haematologica

    pub_type: 临床试验,杂志文章,随机对照试验,评审

    doi:

    authors: Harousseau JL

    更新日期:1999-06-01 00:00:00

  • In vitro modulation of bcl-2 protein expression, drug-induced apoptosis and cytotoxicity by interleukin-10 in chronic lymphocytic leukemia.

    abstract::Interleukin-10 failed to modify either the percentage of bcl-2+ cells or the number of bcl-2 molecules, or to reduce 2-chlorodeoxyadenosine- and fludarabine-induced apoptosis. The cytokine at 0.1 ng/mL induced an increase of cell survival both in the absence or in the presence of 2-chlorodeoxyadenosine, while no diffe...

    journal_title:Haematologica

    pub_type: 信件

    doi:

    authors: Morabito F,Filangeri M,Sculli G,Oliva B

    更新日期:1998-11-01 00:00:00

  • Hepcidin: from discovery to differential diagnosis.

    abstract::Although iron is essential for living organisms to survive, its reactive properties require strict regulation in order to prevent toxic effects. Hepcidin, a liver produced peptide hormone, is thought to be the central regulator of body iron metabolism. Its production is mainly controlled by the erythropoietic activity...

    journal_title:Haematologica

    pub_type: 杂志文章,评审

    doi:10.3324/haematol.11705

    authors: Kemna EH,Tjalsma H,Willems HL,Swinkels DW

    更新日期:2008-01-01 00:00:00

  • A dose exploration, phase I/II study of administration of continuous erythropoietin receptor activator once every 3 weeks in anemic patients with multiple myeloma receiving chemotherapy.

    abstract:BACKGROUND AND OBJECTIVES:Continuous erythropoietin receptor activator (C.E.R.A.) is an innovative agent with unique erythropoietin receptor activity and a prolonged half-life, which has the potential for administration at extended dosing intervals. The objectives of this dose-finding study were to evaluate the hemoglo...

    journal_title:Haematologica

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.3324/haematol.10730

    authors: Dmoszynska A,Kloczko J,Rokicka M,Hellmann A,Spicka I,Eid JE

    更新日期:2007-04-01 00:00:00

  • Prevalence of phenotypic activated protein C resistance (APCR) in venous thromboembolic patients.

    abstract::Until the discovery of activated protein C resistance (APCR), less than 10% of patients with venous thromboembolism (VT) showed defects in proteins involved in the inhibition of coagulation. APCR is caused by a single point mutation in the factor V gene, and it is accepted that APCR is associated with an increased ris...

    journal_title:Haematologica

    pub_type: 信件

    doi:

    authors: Marzo C,Araguás C,Gómez-Arbonés J,Ramírez S

    更新日期:1998-04-01 00:00:00

  • Normal thrombin generation in neonates in spite of prolonged conventional coagulation tests.

    abstract::Conventional coagulation tests might be inadequate to explore mechanisms regulating thrombin generation in neonates, because they do not allow full activation of the reduced levels of protein C. Therefore, they do not reflect the action of pro- and anti-coagulants as does the endogenous thrombin potential assessed in ...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.12566

    authors: Tripodi A,Ramenghi LA,Chantarangkul V,De Carli A,Clerici M,Groppo M,Mosca F,Mannucci PM

    更新日期:2008-08-01 00:00:00

  • Study of hemostasis in pediatric patients with portal vein thrombosis.

    abstract::We describe the behavior of hemostatic variables in children with portal vein thrombosis (PVT) and in a control pediatric population. Hereditary protein C (PC) or protein S (PS) deficiency was not a etiologic factor for PVT in children. Minor signs of consumption of coagulation factors II, V, fibrinogen and hyperfibri...

    journal_title:Haematologica

    pub_type: 信件

    doi:

    authors: Seixas CA,Hessel G,Siqueira LH,Machado TF,Gallizoni AM,Annichino-Bizzacchi JM

    更新日期:1998-10-01 00:00:00

  • Association between prolonged bleeding time and gastrointestinal hemorrhage in 102 patients with liver cirrhosis: results of a retrospective study.

    abstract:BACKGROUND:Gastrointestinal bleeding is a frequent complication of liver cirrhosis (LC) and represents an important warning sign of imminent death. Platelet dysfunction is an abnormality occurring prevalently in severe liver failure, and could well predispose to bleeding. METHODS:One hundred and two patients with live...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Violi F,Leo R,Basili S,Ferro D,Cordova C,Balsano F,CALC Group.

    更新日期:1994-01-01 00:00:00

  • Activity of everolimus (RAD001) in relapsed and/or refractory multiple myeloma: a phase I study.

    abstract::The mammalian target of rapamycin plays an important role in multiple myeloma. The allosteric mammalian target of rapamycin inhibitor everolimus has long been approved for immunosuppression and has shown activity in certain cancers. This investigator-initiated phase I trial explored the use of everolimus in relapsed a...

    journal_title:Haematologica

    pub_type: 杂志文章,多中心研究

    doi:10.3324/haematol.2014.116269

    authors: Günther A,Baumann P,Burger R,Kellner C,Klapper W,Schmidmaier R,Gramatzki M

    更新日期:2015-04-01 00:00:00

  • Interleukin-3 promotes hemangioblast development in mouse aorta-gonad-mesonephros region.

    abstract:BACKGROUND:The hemangioblast is a bi-potential precursor cell with the capacity to differentiate into hematopoietic and vascular cells. In mouse E7.0-7.5 embryos, the hemangioblast can be identified by a clonal blast colony-forming cell (BL-CFC) assay or single cell OP9 co-culture. However, the ontogeny of the hemangio...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2009.014241

    authors: He WY,Lan Y,Yao HY,Li Z,Wang XY,Li XS,Zhang JY,Zhang Y,Liu B,Mao N

    更新日期:2010-06-01 00:00:00

  • Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B-cell lymphoma: a phase I study by the Fondazione Italiana Linfomi.

    abstract::Despite improvements in standard therapy with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone for patients with untreated, diffuse large B-cell lymphoma, up to 40% of these patients relapse. Lenalidomide alone or in combination with rituximab has been shown to be active in relapsed/refractory aggr...

    journal_title:Haematologica

    pub_type: 杂志文章,多中心研究

    doi:10.3324/haematol.2013.085134

    authors: Chiappella A,Tucci A,Castellino A,Pavone V,Baldi I,Carella AM,Orsucci L,Zanni M,Salvi F,Liberati AM,Gaidano G,Bottelli C,Rossini B,Perticone S,De Masi P,Ladetto M,Ciccone G,Palumbo A,Rossi G,Vitolo U,Fondazione It

    更新日期:2013-11-01 00:00:00

  • Rapid induction of single donor chimerism after double umbilical cord blood transplantation preceded by reduced intensity conditioning: results of the HOVON 106 phase II study.

    abstract::Double umbilical cord blood transplantation is increasingly applied in the treatment of adult patients with high-risk hematological malignancies and has been associated with improved engraftment as compared to that provided by single unit cord blood transplantation. The mechanism of improved engraftment is, however, s...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2014.106690

    authors: Somers JA,Braakman E,van der Holt B,Petersen EJ,Marijt EW,Huisman C,Sintnicolaas K,Oudshoorn M,Groenendijk-Sijnke ME,Brand A,Cornelissen JJ

    更新日期:2014-11-01 00:00:00

  • MOHITO, a novel mouse cytokine-dependent T-cell line, enables studies of oncogenic signaling in the T-cell context.

    abstract::The mouse pro-B cell line Ba/F3 has gained major interest as a model system to investigate oncogenic tyrosine kinases and to determine the efficacy of kinase inhibitors. While Ba/F3 cells are suitable to study oncogenic kinases derived from various cell types, the signaling networks in Ba/F3 cells are B-cell specific....

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2010.035931

    authors: Kleppe M,Mentens N,Tousseyn T,Wlodarska I,Cools J

    更新日期:2011-05-01 00:00:00

  • The association of cyclophosphamide and dexamethasone in advanced refractory multiple myeloma patients.

    abstract::VAD is the most active regimen in refractory myeloma patients; however, the role of vincristine and doxorubicin remains unclear. Relatively high doses of cyclophosphamide (3.6 g/sqm) increased the response rate and survival in resistant MM. Cyclophosphamide and dexamethasone were administered to 28 patients with advan...

    journal_title:Haematologica

    pub_type: 临床试验,杂志文章,多中心研究

    doi:

    authors: Celesti L,Clavio M,Poggi A,Casciaro S,Vallebella E,Gobbi M

    更新日期:1997-05-01 00:00:00

  • Feasibility of a mixed inpatient-outpatient model of peripheral blood stem cell transplantation for multiple myeloma.

    abstract:BACKGROUND AND OBJECTIVES:A progressively growing number of peripheral blood stem cell transplants (PBSCTs) are being performed in patients with newly diagnosed multiple myeloma (MM) since they are ever more frequently being offered as up-front therapy. Furthermore, there are considerable concerns regarding the appropr...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Morabito F,Martino M,Stelitano C,Oliva E,Kropp M,Irrera G,Console G,Fujo M,Messina G,Molica S,Callea V,Iacopino P

    更新日期:2002-11-01 00:00:00

  • In vivo reduction of erythrocyte oxidant stress in a murine model of beta-thalassemia.

    abstract:BACKGROUND AND OBJECTIVES:Oxidant damage is an important contributor to the premature destruction of erythrocytes and anemia in thalassemias. To assess the extent of oxidant damage of circulating erythrocytes and the effects of antioxidant therapy on erythrocyte characteristics and anemia, we used a mouse model of huma...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: de Franceschi L,Turrini F,Honczarenko M,Ayi K,Rivera A,Fleming MD,Law T,Mannu F,Kuypers FA,Bast A,van der Vijgh WJ,Brugnara C

    更新日期:2004-11-01 00:00:00

  • t(3;11)(q12;p15)/NUP98-LOC348801 fusion transcript in acute myeloid leukemia.

    abstract::In a case of acute myeloid leukemia we report molecular cytogenetic findings of a t(3;11)(q12;p15), characterized as a new NUP98 translocation rearranging with LOC348801 at chromosome 3. NUP98 involvement was detected by fluorescence in situ hybridization. 3'-RACE-PCR showed nucleotide 1718 (exon 13) of NUP98 was fuse...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.12945

    authors: Gorello P,Brandimarte L,La Starza R,Pierini V,Bury L,Rosati R,Martelli MF,Vandenberghe P,Wlodarska I,Mecucci C

    更新日期:2008-09-01 00:00:00

  • Prognostic value of quantitative analysis of WT1 gene transcripts in adult acute lymphoblastic leukemia.

    abstract::We quantified Wilm's tumor gene (WT1) using a real time quantitative polymerase chain reaction in 20 adult patients with acute lymphoblastic leukemia at presentation. A WT1 level greater than 906 (median value for the whole series) was a significant predictor of a poor disease-free and overall survival in uni- and mul...

    journal_title:Haematologica

    pub_type: 信件

    doi:

    authors: Chiusa L,Francia di Celle P,Campisi P,Ceretto C,Marmont F,Pich A

    更新日期:2006-02-01 00:00:00

  • Chronic sympathetic driven hypertension promotes atherosclerosis by enhancing hematopoiesis.

    abstract::Hypertension is a major, independent risk factor for atherosclerotic cardiovascular disease. However, this pathology can arise through multiple pathways, which could influence vascular disease through distinct mechanisms. An overactive sympathetic nervous system is a dominant pathway that can precipitate in elevated b...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2018.192898

    authors: Al-Sharea A,Lee MKS,Whillas A,Michell DL,Shihata WA,Nicholls AJ,Cooney OD,Kraakman MJ,Veiga CB,Jefferis AM,Jackson K,Nagareddy PR,Lambert G,Wong CHY,Andrews KL,Head GA,Chin-Dusting J,Murphy AJ

    更新日期:2019-03-01 00:00:00

  • Bone marrow transplantation for severe aplastic anemia: the Barcelona Hospital Clinic experience.

    abstract:BACKGROUND AND OBJECTIVE:The outcome of patients with severe aplastic anemia (SAA) has improved considerably over the last decades. Bone marrow transplantation (BMT) is the treatment of choice in young patients who have an HLA-identical sibling donor. This study analyzes the outcome and factors related to survival in p...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Hernández-Boluda JC,Marín P,Carreras E,Aguilar JL,Grañena A,Rozman C,Montserrat E

    更新日期:1999-01-01 00:00:00

  • Multivariate analysis of Hodgkin's disease prognosis. Fitness and use of a directly predictive equation.

    abstract::The main purpose of this work is to give methodologic details and further verification regarding the predictive system recently elaborated for Hodgkin's disease (HD) patients, by which, under standard accuracy and conventional treatment, patient survival can be directly estimated (within a given confidence interval) w...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Gobbi PG,Gobbi PG,Mazza P,Zinzani PL

    更新日期:1989-01-01 00:00:00

  • Protein arginine methyltransferase 6 controls erythroid gene expression and differentiation of human CD34+ progenitor cells.

    abstract::Hematopoietic differentiation is driven by transcription factors, which orchestrate a finely tuned transcriptional network. At bipotential branching points lineage decisions are made, where key transcription factors initiate cell type-specific gene expression programs. These programs are stabilized by the epigenetic a...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:10.3324/haematol.2017.174516

    authors: Herkt SC,Kuvardina ON,Herglotz J,Schneider L,Meyer A,Pommerenke C,Salinas-Riester G,Seifried E,Bonig H,Lausen J

    更新日期:2018-01-01 00:00:00

  • Difference in gene expression between human fetal liver and adult bone marrow mesenchymal stem cells.

    abstract:BACKGROUND AND OBJECTIVES:Mesenchymal stem cells (MSC) are progenitor cells that are capable of differentiating into mesenchymal tissues. Fetal and adult MSC have similar morphology but differ in proliferative, differentiating and immunosuppressive properties. Further exploring their differences could help in choosing ...

    journal_title:Haematologica

    pub_type: 杂志文章

    doi:

    authors: Götherström C,West A,Liden J,Uzunel M,Lahesmaa R,Le Blanc K

    更新日期:2005-08-01 00:00:00